Yes! We Can End TB
Led by Countries. Powered by People. Driven by Researchers.
At the Institute of Infectious Disease and Molecular Medicine (IDM), our researchers are turning commitment into action by advancing locally led solutions to one of South Africa’s biggest health challenges.
From decoding how TB spreads, to developing better diagnostics, treatments, and vaccines, IDM scientists are helping to ensure that national priorities are backed by world-class research and real-world impact.
We work closely with communities and global partners, therefore our researchers are not only generating knowledge they are also powering the people and systems needed to end TB.
Current TB News
In the Spotlight: The invisible fuel driving our TB epidemic
A recent article highlights a critical but often overlooked driver of South Africa’s tuberculosis (TB) epidemic: asymptomatic TB, these are individuals who carry active TB disease but show no symptoms.
Read more
Uncovering TB’s Survival Strategy in Lipid-Rich Environments
Dr Tiago Beites shares insights into how Mycobacterium tuberculosis, adapts to one of the body’s more unusual defence environments.
Read more
TB harnesses part of immune defence system to cause infection
Scientists from UCT have contributed to an international study that shed new light on why humans and animals are so susceptible to contracting tuberculosis.
Read more
Highlights from 2025
Hidden Enemy: Why TB Remains One of the World’s Deadliest Diseases
An exciting review in Nature Reviews Microbiology details recent insights into the age-old interaction between Mtb and humans.
Read more
‘This is an investment in dignity’
FreeOfTB, founded by IDM Affiliate Member, Prof Keertan Dheda, is dedicated to supporting underprivileged TB patients and vulnerable communities through social, clinical, and educational outreach.
Read more
Take TB testing to the community to detect asymptomatic cases
To cut transmission, finding TB earlier is critical, new research finds.
Read more
AI helps tailor TB and malaria drugs for African patients
New UCT-led research uses AI to personalise malaria and TB dosing for Africa’s genetically diverse populations.
Read more
Highlights from 2024
Empowering Collaboration: Highlights from the #ENDTB Event
The #ENDTB event hosted by IDM showcased collaborative efforts to combat tuberculosis, emphasizing the importance of knowledge exchange.
Read more
